close
close

Clinical considerations for the use of GLP-1 RA before endoscopy


Clinical considerations for the use of GLP-1 RA before endoscopy

The rapidly growing popularity of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has sparked discussions about lesser-known side effects that are now coming to light as so many patients take these drugs for diabetes and obesity. There is also the potential for more patients to take them as intended as they are being evaluated in hepatology […]

The use of biguanides and dipeptidyl peptidase-4 inhibitors has similar effects in diabetics


The use of biguanides and dipeptidyl peptidase-4 inhibitors has similar effects in diabetics

1. Biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors show no differences in major cardiac or cerebrovascular events, diabetic complications, or death in the Japanese population. Evidence assessment level: 2 (Good) The first line pharmacological intervention for type 2 diabetes mellitus (T2DM) includes biguanides and dipeptidyl peptidase 4 (DPP-4) inhibitors. Interestingly, there are different guidelines worldwide on […]